Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Am J Reprod Immunol. 2020 Sep 21;85(3):e13343. doi: 10.1111/aji.13343

Table 3a.

Association between CD14+HLA-DRlo/- monocytic cells percent gated and advanced ovarian cancer stage.

Monocytic cells Crude OR (95% CI) Adj. OR (95% CI)
Low (<3.6%) 1.00 (ref.) 1.00 (ref.)
Intermediate (3.6–9.2%) 2.07 (1.05–4.08) 1.51 (0.54–4.18)
High (≥9.3%) 3.49 (1.71–7.15) 3.33 (1.04–10.64)
P for trend 0.0005 0.04

Multivariable logistic regression adjusted for shipment, grade and tumor histotype